Anders Jorsal

Summary

Affiliation: Steno Diabetes Center
Country: Denmark

Publications

  1. doi The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy
    A Jorsal
    Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark
    Mol Genet Metab 94:347-51. 2008
  2. doi Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy
    Anders Jorsal
    Steno Diabetes Center, Gentofte, Denmark
    Kidney Int 74:649-54. 2008
  3. doi Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
    A Jorsal
    Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark
    Diabetologia 51:2100-7. 2008
  4. pmc Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy
    Maria Lajer
    Steno Diabetes Center, Gentofte, Denmark
    Diabetes Care 33:1567-72. 2010
  5. ncbi Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy
    Maria Lajer
    Steno Diabetes Center, Niels Steensens Vej 1, 2820 Gentofte, Denmark
    Diabetes Care 31:747-52. 2008
  6. doi Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function
    Maria Lajer
    Steno Diabetes Center, Gentofte, Denmark
    Platelets 21:525-32. 2010
  7. ncbi Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients
    Maria Lajer
    Steno Diabetes Center, Niels Steensens Vej 2, DK 2820 Gentofte, Denmark
    Nephrol Dial Transplant 22:3235-9. 2007
  8. doi Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial
    Katrine J Schjoedt
    1Steno Diabetes Center, Niels Steensens Vej 1, 2820 Gentofte, Denmark
    Nephrol Dial Transplant 24:3343-9. 2009

Detail Information

Publications8

  1. doi The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy
    A Jorsal
    Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark
    Mol Genet Metab 94:347-51. 2008
    ..040). In conclusion, the Pro12Ala polymorphism is not associated with type 1 diabetic nephropathy. The Ala-allele is associated with enhanced decline in GFR and predicts ESRD and all-cause mortality in patients with nephropathy...
  2. doi Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy
    Anders Jorsal
    Steno Diabetes Center, Gentofte, Denmark
    Kidney Int 74:649-54. 2008
    ..These studies show that high serum adiponectin levels predict mortality and progression to end stage renal disease in type I diabetic patients...
  3. doi Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
    A Jorsal
    Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark
    Diabetologia 51:2100-7. 2008
    ..The aim of this study was to investigate the predictive value of plasma levels of osteoprotegerin in relation to mortality, cardiovascular events and deterioration in kidney function in patients with type 1 diabetes...
  4. pmc Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy
    Maria Lajer
    Steno Diabetes Center, Gentofte, Denmark
    Diabetes Care 33:1567-72. 2010
    ..The aim of this study was to investigate GDF-15 levels in relation to all-cause mortality, cardiovascular mortality and morbidity, decline in glomerular filtration rate (GFR), and progression toward end-stage renal disease (ESRD)...
  5. ncbi Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy
    Maria Lajer
    Steno Diabetes Center, Niels Steensens Vej 1, 2820 Gentofte, Denmark
    Diabetes Care 31:747-52. 2008
    ....
  6. doi Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function
    Maria Lajer
    Steno Diabetes Center, Gentofte, Denmark
    Platelets 21:525-32. 2010
    ..85) nor rate of decline in GFR (p = 0.69). Plasma sCD40L is elevated in T1DM nephropathy but is not a predictor of all-cause mortality, cardiovascular mortality and morbidity or deterioration of kidney function..
  7. ncbi Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients
    Maria Lajer
    Steno Diabetes Center, Niels Steensens Vej 2, DK 2820 Gentofte, Denmark
    Nephrol Dial Transplant 22:3235-9. 2007
    ..Therefore, we investigated the association between two polymorphisms -381T/C and 1551G/A of the BNP gene, plasma NT-proBNP levels and mortality prognosis in 380 type 1 diabetic patients with and without diabetic nephropathy...
  8. doi Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial
    Katrine J Schjoedt
    1Steno Diabetes Center, Niels Steensens Vej 1, 2820 Gentofte, Denmark
    Nephrol Dial Transplant 24:3343-9. 2009
    ..The aim of our study was to establish if spironolactone affects the ability to autoregulate GFR...